These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7555198)

  • 21. Interventional pharmacotherapy.
    Philipp R; Grech ED
    BMJ; 2003 Jul; 327(7405):43-6. PubMed ID: 12842958
    [No Abstract]   [Full Text] [Related]  

  • 22. Evidence based management of patients undergoing PCI. Conclusion.
    Lasala JM; Mehran R; Moses JW; Popma JJ; Reiner JS; Sharma SK; Vetrovec GW
    Catheter Cardiovasc Interv; 2010 Mar; 75 Suppl 1():S43-5. PubMed ID: 20333707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A mainstay drug underperforms. But a bedside test makes it easier to spot "aspirin resistance".
    Heart Advis; 2004 Aug; 7(8):3. PubMed ID: 15551431
    [No Abstract]   [Full Text] [Related]  

  • 24. Clopidogrel and percutaneous coronary intervention.
    Cannon C
    Lancet; 2002 Jan; 359(9301):169. PubMed ID: 11809292
    [No Abstract]   [Full Text] [Related]  

  • 25. [Restenosis after percutaneous transluminal angioplasty: II. Possibilities for pharmacologic intervention].
    Böger RH; Bode-Böger SM; Alfke H
    Vasa; 1996; 25(1):21-31. PubMed ID: 8851262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rationale and use of antiplatelet and antithrombotic drugs during cardiovascular interventions.
    Cuisset T; Mudra H; Muller O; Vogt P; Angelillo-Scherrer A; Huber K
    EuroIntervention; 2008 Aug; 4(2):183-6. PubMed ID: 19110780
    [No Abstract]   [Full Text] [Related]  

  • 27. Optimal treatment of acute coronary syndromes--an evolving strategy.
    Boden WE; McKay RG
    N Engl J Med; 2001 Jun; 344(25):1939-42. PubMed ID: 11419433
    [No Abstract]   [Full Text] [Related]  

  • 28. Future trials of antiplatelet agents in cardiac ischemia.
    Throckmorton DC
    N Engl J Med; 2001 Jun; 344(25):1937-9. PubMed ID: 11419432
    [No Abstract]   [Full Text] [Related]  

  • 29. The ideal reperfusion strategy for the ST-segment elevation myocardial infarction patient with expected delay to percutaneous coronary intervention: paradise lost or paradise renamed?
    Henry TD; Larson DM
    JACC Cardiovasc Interv; 2009 Oct; 2(10):931-3. PubMed ID: 19850251
    [No Abstract]   [Full Text] [Related]  

  • 30. The disappointing results of PTCA in the uraemic patient--are stents the answer?
    Haller C; Kübler W
    Nephrol Dial Transplant; 1999 Nov; 14(11):2582-4. PubMed ID: 10534492
    [No Abstract]   [Full Text] [Related]  

  • 31. Interventions for left main coronary artery disease: indications, technique and results.
    Park SJ
    Indian Heart J; 1998 Oct; 50 Suppl 1():74-8. PubMed ID: 9824911
    [No Abstract]   [Full Text] [Related]  

  • 32. Abciximab to prevent vessel closure after angioplasty.
    Med Lett Drugs Ther; 1995 Jun; 37(950):52-3. PubMed ID: 7760769
    [No Abstract]   [Full Text] [Related]  

  • 33. Antithrombotic therapy use after percutaneous coronary intervention and stent implantation in patients taking chronic oral anticoagulation.
    Ruiz-Nodar JM; Marín F; Lip GY
    JACC Cardiovasc Interv; 2008 Jun; 1(3):329; author reply 330-1. PubMed ID: 19463322
    [No Abstract]   [Full Text] [Related]  

  • 34. Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts following percutaneous transluminal coronary angioplasty.
    Stein PD; Dalen JE; Goldman S; Schwartz L; Turpie AG; Théroux P
    Chest; 1992 Oct; 102(4 Suppl):508S-515S. PubMed ID: 1395831
    [No Abstract]   [Full Text] [Related]  

  • 35. [Platelet activation in acute coronary syndrome and interventional therapy].
    Bigalke B; Lindemann S; Gawaz M
    Hamostaseologie; 2007 Dec; 27(5):338-43. PubMed ID: 18060243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stent thrombosis--risk assessment and prevention.
    Motovska Z; Knot J; Widimsky P
    Cardiovasc Ther; 2010 Oct; 28(5):e92-100. PubMed ID: 20553282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triple antithrombotic management after stent implantation: when and how?
    Dewilde W; Berg JT
    Heart; 2010 Jan; 96(1):73; author reply 73-4. PubMed ID: 20019212
    [No Abstract]   [Full Text] [Related]  

  • 38. Introduction: glycoprotein IIb/IIIa blockers in the era of metallic coronaries.
    Goldschmidt-Clermont PJ
    J Invasive Cardiol; 2002 Dec; 14 Suppl E():1E. PubMed ID: 12668856
    [No Abstract]   [Full Text] [Related]  

  • 39. Acute coronary syndromes: clearing up controversies in clopidogrel use.
    Cardiovasc J S Afr; 2006; 17(4):213-4. PubMed ID: 17001429
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes.
    Campbell P
    N Engl J Med; 2001 Nov; 345(21):1573-4; author reply 1574-5. PubMed ID: 11794228
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.